Home/Filings/4/0001127602-25-013785
4//SEC Filing

Miller Derek 4

Accession 0001127602-25-013785

CIK 0000318154other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 8:58 PM ET

Size

7.6 KB

Accession

0001127602-25-013785

Insider Transaction Report

Form 4
Period: 2025-05-06
Miller Derek
SVP, Human Resources
Transactions
  • Award

    Common Stock

    2025-05-06+96110,189 total
  • Award

    Nqso (Right to Buy)

    2025-05-06$270.44/sh+6,214$1,680,5146,214 total
    Exercise: $270.44From: 2026-05-06Exp: 2035-05-06Common Stock (6,214 underlying)
Footnotes (3)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 105 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F3]These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001917312

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:58 PM ET
Size
7.6 KB